BIAF - BioAffinity Technologies Inc
0.2128
0.002 0.893%
Share volume: 2,047,501
Last Updated: 05-07-2025
Business Services/Services – Research, Development, Testing Labs:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.21
0.00
0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2023 | 11-14-2024 | 05-15-2024 | 08-14-2024 | 11-14-2024 | |
| Total revenue | 921.000 | 19.738 K | 298.484 K | 2.213 M | 2.406 M | 2.398 M | 2.350 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | -74.704 K | 0.000 | 0.000 | 0.000 | |
| Gross profit | 921.000 | 19.738 K | 298.484 K | 2.288 M | 2.406 M | 2.398 M | 2.350 M | |
| 2,043.11% | 1,412.23% | 666.56% | 5.17% | -0.36% | -1.97% | |||
| Operating expenses | 1.537 M | 1.775 M | 2.461 M | 2.742 M | 2.629 M | 2.927 M | 2.733 M | |
| Selling general and admin | 1.148 M | 1.405 M | 2.024 M | 2.214 M | 2.186 M | 2.473 M | 2.365 M | |
| Research and development | 389.245 K | 370.385 K | 436.798 K | 528.169 K | 442.599 K | 453.895 K | 368.202 K | |
| Total expenses | 1.559 M | 1.798 M | 2.593 M | 4.630 M | 4.352 M | 4.485 M | 4.324 M | |
| 15.34% | 44.21% | 78.58% | -6.02% | 3.08% | -3.59% | |||
| Operating income | -1.558 M | -1.778 M | -2.295 M | -2.342 M | -1.945 M | -2.088 M | -1.974 M | |
| Ebit | -1.558 M | -1.778 M | -2.307 M | -2.358 M | -1.958 M | -2.088 M | -1.979 M | |
| Pretax income | -1.521 M | -1.736 M | -2.289 M | -2.371 M | -1.958 M | -2.105 M | -1.998 M | |
| 14.11% | 31.86% | 3.60% | -17.41% | 7.49% | -5.06% | |||
| Income tax | 11.819 K | 4.587 K | 2.294 K | 2.293 K | 3.672 K | 5.419 K | 2.559 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.533 M | -1.740 M | -2.291 M | -2.373 M | -1.962 M | -2.110 M | -2.001 M | |
| -13.53% | -31.65% | -3.59% | 17.33% | -7.57% | 5.19% |
